Log In
Print
BCIQ
Print
Print this Print this
 

RDX009

  Manage Alerts
Collapse Summary General Information
Company Ardelyx Inc.
DescriptionG protein-coupled bile acid receptor 1 (GPBAR1) (TGR5) inhibitor
Molecular Target G protein-coupled bile acid receptor 1 (GPBAR1) (TGR5)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today